Serum Lactate Dehydrogenase as an Indicator of Maternal and Neonatal Outcomes in Hypertensive Disorders of Pregnancy

Authors

  • Sadia Zainab Department of Gyne & obs, Combined Military Hospital Bahawalpur/National University of Medical Sciences (NUMS) Pakistan
  • Amina Akbar Department of Gyne & obs, Pakistan Air Force Hospital, Islamabad/National University of Medical Sciences (NUMS) Pakistan
  • Ambreen Ehsan Department of Gyne & obs, Combined Military Hospital Jhelum/ National University of Medical Sciences (NUMS) Pakistan
  • Sidra Mushtaq Department of Gyne & obs, Bahawal Victoria Hospital, Bhawalpur Pakistan
  • Humaira Tabbasum Department of Gyne & obs, Combined Military Hospital Lahore/National University of Medical Sciences (NUMS) Pakistan
  • Mobeen Ikram Department of Anesthesia, Combined Military Hospital Kharian/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74i2.10077

Keywords:

Eclampsia, HELLP syndrome, Lactate dehydrogenase, Pre-eclampsia, Preterm birth

Abstract

Objective: To ascertain the sensitivity and specificity of serum lactate dehydrogenase as an indicator for maternal and
neonatal outcomes in hypertensive disorders of pregnancy.

Study Design: Cross-sectional, analytical study.

Place and Duration of Study: Departments of Anesthesia and Gynecology & Obstetrics, Combined Military Hospital, Okara
Cantt Pakistan, from Apr to Sep 2018.

Methodology: Eighty-six pregnant women with pregnancy-induced hypertension were included in our study. Group-A
included pregnant women with raised serum LDH, and Group-B included pregnant women with normal LDH levels. The
patients were followed up until delivery and hospital discharge. Maternal and neonatal outcomes were studied.

Results: The progression to hemolysis elevated liver enzyme low platelet (HELLP) syndrome was 4(4.8%) in Group-A versus
zero in Group-B, p=0.022. The two groups did not vary in mode of delivery (cesarean section in 28 vs. 33); preterm delivery (22
versus 15); intrauterine growth retardation (8 vs. 6); intrauterine demise (9 vs 5); low APGAR at birth (13 vs. 7); eclampsia (3
vs. 3) which were comparable between the two groups, p-value>0.05. For overall maternal outcomes, the sensitivity for raised
LDH was 57.1% and specificity 53.3%. The sensitivity was 51.2%, and the specificity was 54.7% for overall neonatal outcomes.

Conclusion: Elevated serum LDH alone in pregnancy-induced hypertension cannot considered as a prognostic indicator for
maternal and neonatal adverse outcomes, except HELLP syndrome

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Wang W, Xie X, Yuan T, Wang Y, Zhoa F, Zhou Z et al..

Epidemiological Trends of Maternal Hypertensive Pregnancy

Disorders at The Global, Regional, And National Levels: A

Population‐Based Study. BMC Pregnancy Childbirth 2021; 21:

https://doi.org/10.1186/s12884-021-03809-2

Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and

regional estimates of pre-eclampsia and eclampsia: a systematic

review. Eur J Obstet Gynecol Reprod Biol 2013; 170(1): 1-7.

Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB,

Goudar S, et al. The Incidence of Pregnancy Hypertension in

India, Pakistan, Mozambique and Nigeria: A Prospective

Population Level Analysis. PLoS Med.2019; 16(4): e1002783.

https://doi.org/10.1371/journal.pmed.1002783

Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Trisha AD et

al. Prevalence of Pre-Eclampsia and the Associated Risk Factors

among Pregnant Women In Bangladesh. Scientific Rep 2021; 11:

https://doi.org/10.1038/s41598-021-00839-w

Kongwattanakul K, Saksiriwuttho P, Chaiyarach S,

Thepsuthammarat K. Incidence, Characteristics, Maternal

Complications, And Perinatal Outcomes Associated With PreEclampsia With Severe Features And Hellp Syndrome. Int J

Womens Health 2018; 17(10): 371-377.

https://doi.org/10.2147/IJWH.S168569

Liu Y, Wen L, Chen H, Chen Y, Duan W, Kang Y, et al. Serum

Lactate Dehydrogenase Can Be Used As A Factor For ReEvaluating First-Relapsed Multiple Myeloma. Acta Haematol

; 143(6): 559-566. https://doi.org/10.1159/000505737

Zhu W, Ma Y, Guo W, Lu J, Li X, Wu J, et al. Serum Level Of

Lactate Dehydrogenase Is Associated With Cardiovascular

Disease Risk As Determined By The Framingham Risk Score

And Arterial Stiffness In A Health-Examined Population In

China. Int J Gen Med 2022; 15: 11-17.

https://doi.org/10.2147/IJGM.S337517

Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. PreEclampsia: Pathophysiology, Diagnosis, and Management. Vasc

Health Risk Manag 2011; 7: 467-474.

https://doi.org/10.2147/VHRM.S20181

Burwick RM, Rincon M, Beeraka SS, Gupta M, Feinberg BB.

Evaluation of Hemolysis as a Severe Feature of Preeclampsia.

Hypertension 2018; 72(2): 460-465.

https://doi.org/10.1161/HYPERTENSIONAHA.118.11211

Manolov V, Marinov B, Masseva A, Vasilev V. Plasma D-Dimer

Levels In Pre-Eclampsia. Akush Ginekol 2014; 53(Suppl 2): 15-

Matli YS, Lyimo MA, Luzzatto L, Massawe SN. Hypertensive

Disorders Of Pregnancy Are Associated With An Inflammatory

State: Evidence From Hematological Findings And Cytokine

Levels. BMC Pregnancy Childbirth 2019; 19(1): 237.

https://doi.org/10.1186/s12884-019-2383-7

Lin Y, Dong YB, Liu YR, Zhang Y, Li HY, Song W. Correlation

Between Corin, N-Terminal Pro-Atrial Natriuretic Peptide And

Neonatal Adverse Prognostic In Hypertensive Disorders Of

Pregnancy. Pregnancy Hypertens 2021; 23: 73-78.

https://doi.org/10.1016/j.preghy.2020.11.007

Salako BL, Odukogbe AT, Olayemi O, Adedapo KS, Aimakhu

CO, Alu FE, et al. Serum Albumin, Creatinine, Uric Acid And

Hypertensive Disorders Of Pregnancy. East Afr Med J 2003;

(8): 424-428. https://doi.org/10.4314/eamj.v80i8.8735

Vyakaranam S, Bhongir AV, Patlolla D, Chintapally R. Study Of

Serum Uric Acid And Creatinine In Hypertensive Disorders Of

Pregnancy. Int J Med Sci Public Health 2015; 4(10): 1424-1428.

https://doi.org/10.5455/ijmsph.2015.15042015294

Gordon JS, Wood CT, Luc JGY, Watson RA, Maynes EJ, Choi JH,

et al. Clinical Implications Of Ldh Isoenzymes In Hemolysis

And Continuous-Flow Left Ventricular Assist Device-Induced

Thrombosis. Artif Organs 2020; 44(3): 231-238.

https://doi.org/10.1111/aor.13565

Barcellini W, Fattizzo B. Clinical applications of hemolytic

markers in the differential diagnosis and management of

hemolytic anemia. Dis Markers 2015; 2015: 635670.

https://doi.org/10.1155/2015/635670

Haram K, Svendsen E, Abildgaard U. The HELLP Syndrome:

Clinical Issues and Management. A Review. BMC Pregnancy

Childbirth. 2009; 9: 8. https://doi.org/10.1186/1471-2393-9-8

Khidri FF, Shaikh F, Khowaja IU, Riaz H. Role Of Lactate

Dehydrogenase In The Prediction Of Severity In Pre-Eclampsia.

Curr Hypertens Rev 2020; 16(3): 223-228.

https://doi.org/10.2174/1573402116666200720001032

Afroz R, Akhter QS, Sultana S. Serum Lactate Dehydrogenase

(LDH) In Severe Pre-Eclampsia. Bangladesh Soc Physiol 2015;

(2): 71-75

Vinitha PM, Chellatamizh M and Padmanaban S. Role Of Serum

Ldh In Pre-Eclampsia As A Prognostic Factor- A Cross Sectiona;

Case Control Study In Tertiary Care Hospital. Int J Reprod

Contracept Obstet Gynecol 2017; 6(2): 595-598.

Ababio G, Adu-Bonsaffoh K, Narh G, Quaye IKE. Effects Of

Lactate Dehydrogenase (LDH) In Pre-Eclampsia. Clin Med

Biochem 2019; 3: 129.

https://doi.org/10.4172/2471-2663.1000129

Dave A, Maru L, Jain A. LDH (Lactate Dehydrogenase): A

Biochemical Marker for the Prediction of Adverse Outcomes In

Pre-Eclampsia And Eclampsia. J Obstet Gynaecol India 2016;

(1): 23-29. https://doi.org/10.1007/s13224-014-0645-x

Downloads

Published

29-04-2024

How to Cite

1.
Zainab S, Akbar A, Ehsan A, Mushtaq S, Tabbasum H, Ikram M. Serum Lactate Dehydrogenase as an Indicator of Maternal and Neonatal Outcomes in Hypertensive Disorders of Pregnancy. Pak Armed Forces Med J [Internet]. 2024 Apr. 29 [cited 2024 May 24];74(2):451-4. Available from: https://pafmj.org/PAFMJ/article/view/10077

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 > >>